| Literature DB >> 30729135 |
R J Molines-Barroso1, J L Lázaro-Martínez1, J V Beneit-Montesinos1, F J Álvaro-Afonso1, E García-Morales1, Y García-Álvarez1.
Abstract
AIMS: To evaluate the factors that predict reulceration beneath the hallux in people with a history of diabetic foot ulceration.Entities:
Mesh:
Year: 2019 PMID: 30729135 PMCID: PMC6341251 DOI: 10.1155/2019/9038171
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.011
Demographic data of the sample.
| ( | Patients | |
|---|---|---|
| Male/female | 51 (85)/9 (15) | |
| Mean age (years) | 62 ± 8.3 | |
| Diabetes mellitus (years) | 17 ± 13 | |
| Diabetes mellitus type 1/type 2 | 14 (23)/46 (77) | |
| Ankle brachial index | 1.18 ± 0.28 | |
| Retinopathy | 31 (52%) | |
| Nephropathy | 15 (25%) | |
| Body mass index (kg/m2) | 29.4 (±5.4) | |
| Location of the previous ulceration | Hallux | 21 (35) |
| Lesser toes | 13 (22) | |
| Metatarsals | 26 (43) | |
| Glycated haemoglobin (mmol/mol) (%) | 58 ± 9 (7.4 ± 1.2) | |
n (%) for categorical variables; mean ± SD for continuous variables.
Figure 1Evaluation of the first MTPJ dorsiflexion in a weight-bearing position.
Differences between the risk factors for hallux reulceration.
| ( | Hallux reulceration ( | Nonhallux reulceration ( |
| Effect size |
|---|---|---|---|---|
| Male/female | 8 (88.9)/1 (11) | 39 (83)/8 (17) | 0.658 | −0.059a |
| Mean age (years) | 63 ± 9.7 | 62 ± 7.7 | 0.712 | 0.057b |
| Duration of DM (years) | 9 ± 10.8 | 17 ± 13.3 | 0.072 | −0.314b |
| Type 1/type 2 DM | 0 (0)/9 (100) | 13 (28)/34 (72) | 0.072 | 0.241a |
| Body mass index (kg/m2) | 33.6 ± 5.0 | 29.1 ± 5.2 | 0.030∗ | 0.404b |
| Nephropathy | 3 (33) | 12 (25) | 0.628 | 0.065a |
| Retinopathy | 4 (44) | 25 (53) | 0.630 | −0.064a |
| HbA1c (mmol/mol) (%) | 54 ± 6 (7.1 ± 0.8) | 57 ± 8 (7.3 ± 1.1) | 0.599 | −0.207b |
| Ankle brachial index | 1.43 ± 0.46 | 1.24 ± 0.28 | 0.254 | 0.242b |
| Hallux deformity | 3 (33) | 11 (23) | 0.529 | 0.084a |
| Hallux valgus | 1 | 10 | ||
| Metatarsal prominence | 0 | 8 | ||
| Hallux hammertoe | 2 | 2 | ||
| First MTPJ ROM (degrees) | 47.33 ± 19.36 | 49.79 ± 19.15 | 0.734 | −0.064b |
| First MTPJ ROMw-b (degrees) | 21.11 ± 7.15 | 33.26 ± 16.99 | 0.041∗ | −0.422b |
| Functional hallux limitus | 7 (78) | 11 (23) | 0.001∗ | 0.428a |
| Hallux rigidus | 4 (44) | 18 (38) | 0.729 | 0.046a |
| Ankle ROM (degrees) | 90.89 ± 5.49 | 87.60 ± 5.83 | 0.129 | 0.279b |
| Inversion ROM (degrees) | 17.56 ± 4.87 | 16.85 ± 4.64 | 0.697 | 0.074b |
| Eversion ROM (degrees) | 9.33 ± 1.41 | 9.74 ± 3.16 | 0.411 | −0.083b |
| FPI | 2.33 ± 2.50 | 0.66 ± 4.30 | 0.125 | 0.230b |
| Tibiotalar angle X-ray | 112.01 ± 5.11 | 111.77 ± 6.21 | 0.902 | 0.021b |
| Tibiocalcaneal angle X-ray | 67.96 ± 6.94 | 65.88 ± 7.44 | 0.433 | 0.143b |
| Talocalcaneal angle X-ray | 45.11 ± 3.25 | 46.31 ± 6.13 | 0.403 | −0.121b |
| Talar declination angle X-ray | 26.64 ± 4.02 | 25.35 ± 4.16 | 0.397 | 0.156b |
| Calcaneal inclination angle X-ray | 17.91 ± 4.51 | 20.91 ± 6.70 | 0.114 | −0.254b |
| First metatarsal declination angle X-ray | 22.81 ± 2.14 | 24.98 ± 3.50 | 0.024∗ | −0.350b |
Abbreviations: HbA1c: glycated hemoglobin; ROM: range of motion; first MTPJ ROM: range of dorsiflexion of the first metatarsophalangeal joint in the resting position; first MTPJ ROMw-b: range of dorsiflexion of the first metatarsophalangeal joints in the weight-bearing position; FPI: Foot Posture Index. The “nonhallux reulceration” group of patients included other locations of reulceration and patients who did not develop a new ulcer during the follow-up. an (%) for categorical variables; the phi coefficient was used for the chi-square test: representing effect size values of 0.01 as small effect, 0.30 as medium effect, and 0.50 as large effect. bMean ± SD for normally distributed variables; for independent samples, Student's t-test; effect size as the Cohen's d: representing effect size values > 0.2 as small effect, >0.5 as moderate effect, and >0.8 as large effect; d is positive if the mean difference is in the predicted direction.
Figure 2Kaplan-Meier analysis. Time to hallux reulceration for functional hallux limitus. Abbreviations: FHL: functional hallux limitus.